Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NRIP3 divergent transcript (NRIP3-DT) is a primate-specific long non-coding RNA transcribed in a divergent orientation from the promoter region of the NRIP3 gene[1][5]. Divergent lncRNAs, such as NRIP3-DT, are typically associated with the regulation of nearby protein-coding genes, playing roles in chromatin modification, transcriptional control, and developmental gene regulation[2][3]. NRIP3-DT may contribute to neuronal identity and has been implicated in neurodegenerative disease contexts but does not encode a protein and is not considered a conventional therapeutic target[1][2]. Its molecular classification is as a non-coding RNA, and while its precise biological functions are still under investigation, similar transcripts are known for regulatory impact during development and cell differentiation, especially in neurons[2]. There is no evidence for direct drug interaction or for use as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NRIP3 divergent transcript (NRIP3-DT).